Delving Into Participation Trends in Renal Cell Carcinoma Studies

Power Life Sciences

Status: Not yet enrolling

Conditions: Renal Cell Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT06093568

74504682

Details and patient eligibility

About

The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient has been diagnosed with renal cell carcinoma
• Patient is a minimum of 18 years or older
• Patient has self-identified as planning to enroll in a clinical study

Exclusion criteria

• Patient does not understand, sign, and return consent form
• Inability to perform regular electronic reporting
• Patient is pregnant

Trial design